A Comparison of Chemotherapy Used with and without Apatinib for Patients with Ovarian Carcinoma Who Progressed after Standard Regimens: A Systematic Review and Meta-Analysis

OBJECTIVE: This meta-analysis was conducted to compare the therapeutic efficacy and clinical safety of the combination therapy of apatinib plus chemotherapy with that of chemotherapy alone in patients with refractory or recurrent ovarian carcinoma (OC). METHODS: Relevant randomized controlled trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Chao, Jiang, Zhuang-Zhuang, Pan, Bo, Zhang, Xiao-Chun, Liu, Yan-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580656/
https://www.ncbi.nlm.nih.gov/pubmed/34777533
http://dx.doi.org/10.1155/2021/2292907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580656/
https://www.ncbi.nlm.nih.gov/pubmed/34777533
http://dx.doi.org/10.1155/2021/2292907

Ejemplares similares